Our results suggest that CCY-1a-E2 had a growth inhibitory effect in WEHI-3 cells in vitro and also affected leukemia formation in vivo. In addition, treatment with CCY-1a-E2 significantly inhibited the loss of body weight compared with the leukemia group (Fig. 5). This evidence concerns the gene GDI1 and leukemia.